CannapharmaRx Pays Off Convertible Notes
CannaPharmaRx Completes First Harvests
CannaPharmaRx to Hold Investor Conference Call
Cannapharmarx Partners With ICAN To Expand Cannabis Distribution In Latin America
Cannapharmarx Inc (OTCPK: CPMD) has entered into a multi-year supply agreement with ICAN Green S.A. de C.V., part of ICAN Investing Group LLC. This partnership aims to establish a robust distribution
CannaPharmaRx Achieves IMC-GAP and GACP Certifications Completing a Significant Milestone Towards...
CannaPharmaRx Finalizes Multi-Million Dollar Israeli Supply Agreement With Cantek
Cannabis Movers & Shakers: Delaware's New Marijuana Commissioner And Latest Industry Appointments
Delaware Governor's Pick For Marijuana Commissioner Confirmed The Delaware State Senate confirmed Robert Coupe, formerly a Superintendent of the Delaware State Police, to become the first cannabis com
CannaPharmaRx Appoints Dean Medwid as New CEO
CannaPharmaRx, Nasha Ink Pact for Cannabis Strains
CannaPharmaRx Signs Supply Agreement With Y.S.A For Up To $15M Annually Of Commercial Cannabis
CannaPharmaRx, Inc. (OTCPK:CPMD) has signed a supply agreement with Israeli company Y.S.A Holdings. The business arrangement sets forth a supply agreement between the two companies. Under the terms of
CannaPharmaRx Gets CRA License to Start Producing, Selling Cannabis in Canada
CannaPharmaRx Receives Cultivation License From Health Canada and Projects 2023 Revenue Over $30 Million
CALGARY, AB, Dec. 21, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- CannaPharmaRx, Inc. (OTC PINK:CPMD)(the "Company"), an emerging leader in development and operation of ultramodern, highly efficie
CannaPharmaRx Gets Health Canada Cultivation License, Co Sees Annual Sales of $30M
CannaPharmaRx Files Response With Health Canada in Preparation for Cremona Facility Opening
CALGARY, AB / ACCESSWIRE / September 7, 2022 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that on August 31 th
CannaPharmaRx Inks Cannabis Supply Contract With Israel's Spring Medical
CannaPharmaRx (OTCPK:CPMD) signed an agreement with Israeli company Spring Medical Group for commercial cannabis. Under the agreement CannaPharmaRx will cultivate commercial cannabis at its Cremona Fa
CannaPharmaRx Signs Collaboration and Offtake Agreement With Spring Medical Group for Up to $12 Million of Commercial Cannabis
CALGARY, AB / ACCESSWIRE / August 24, 2022 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has signed a M
CannaPharmaRx enters into a genetics transfer agreement with High Profile Cannabis
CannaPharmaRx (OTCPK:CPMD) on Wednesday signed a genetics transfer agreement with Canadian cannabis company High Profile Cannabis. As per the deal, High Profile will deliver live cannabis plants and s
CannaPharmaRx Enters into a Genetics Transfer Agreement with High Profile Cannabis Corp.
CALGARY, AB / ACCESSWIRE / June 29, 2022 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has signed a gen
Is Cannabis Stock Cannapharmarx Inc (CPMD) in the Bottom of the Drug Manufacturers - Specialty & Generic Industry Thursday?
Cannabis stock Cannapharmarx Inc is higher by 11.2% Thursday. Cannapharmarx Inc (CPMD) is near the bottom in its industry group according to InvestorsObserver. CPMD gets an overall rating of 7. That means it scores higher than 7 percent of stocks. Cannap
Pot Stock Surges 16.28% Tuesday: Should You Buy Cannapharmarx Inc (CPMD)?
CPMD, a player in the cannabis market, is higher by 16.28% Tuesday as it outperforms the market as a whole. Cannapharmarx Inc (CPMD) is near the bottom in its sector according to InvestorsObserver. CPMD gets an overall rating of 2. That means it scores
No Data